2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications

被引：7
作者：
Chatterjee, S [1 ]
Gallen, IW [1 ]
Sandler, L [1 ]
机构：
[1] Wycombe Hosp, Ciltern Diabet Ctr, High Wycombe HP11 2TT, Bucks, England
来源：
DIABETES CARE | 1999年 / 22卷 / 07期
关键词：
D O I：
10.2337/diacare.22.7.1226
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1226 / 1227
页数：2
相关论文
共 6 条
  • [1] Strategies toward improved control during insulin lispro therapy in IDDM - Importance of basal insulin
    Ebeling, P
    Jansson, PA
    Smith, U
    Lalli, C
    Bolli, GB
    Koivisto, VA
    [J]. DIABETES CARE, 1997, 20 (08) : 1287 - 1289
  • [2] Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes
    Feinglos, MN
    Thacker, CH
    English, J
    Bethel, MA
    Lane, JD
    [J]. DIABETES CARE, 1997, 20 (10) : 1539 - 1542
  • [3] The human insulin analogue insulin lispro
    Koivisto, VA
    [J]. ANNALS OF MEDICINE, 1998, 30 (03) : 260 - 266
  • [4] Health-related quality-of-life results from multinational clinical trials of insulin lispro - Assessing benefits of a new diabetes therapy
    Kotsanos, JG
    Vignati, L
    Huster, W
    Andrejasich, C
    Boggs, MB
    Jacobson, AM
    Marrero, D
    Mathias, SD
    Patrick, SD
    Zalani, S
    Anderson, J
    [J]. DIABETES CARE, 1997, 20 (06) : 948 - 958
  • [5] Insulin lispro in CSII - Results of a double-blind crossover study
    Zinman, B
    Tildesley, H
    Chiasson, JL
    Tsui, E
    Strack, T
    [J]. DIABETES, 1997, 46 (03) : 440 - 443
  • [6] ZINMAN B, 1997, DIABETES S1, V46, pA43
1